Literature DB >> 32253274

Fructose Production and Metabolism in the Kidney.

Takahiko Nakagawa1,2, Richard J Johnson3, Ana Andres-Hernando3, Carlos Roncal-Jimenez3, Laura G Sanchez-Lozada4, Dean R Tolan5, Miguel A Lanaspa3.   

Abstract

Understanding fructose metabolism might provide insights to renal pathophysiology. To support systemic glucose concentration, the proximal tubular cells reabsorb fructose as a substrate for gluconeogenesis. However, in instances when fructose intake is excessive, fructose metabolism is costly, resulting in energy depletion, uric acid generation, inflammation, and fibrosis in the kidney. A recent scientific advance is the discovery that fructose can be endogenously produced from glucose under pathologic conditions, not only in kidney diseases, but also in diabetes, in cardiac hypertrophy, and with dehydration. Why humans have such a deleterious mechanism to produce fructose is unknown, but it may relate to an evolutionary benefit in the past. In this article, we aim to illuminate the roles of fructose as it relates to gluconeogenesis and fructoneogenesis in the kidney.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  fructolysis; fructoneogenesis; fructose; gluconeogenesis; glycolysis

Mesh:

Substances:

Year:  2020        PMID: 32253274      PMCID: PMC7217403          DOI: 10.1681/ASN.2019101015

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  90 in total

1.  The metabolism of lactic and pyruvic acids in normal and tumour tissues: Synthesis of carbohydrate.

Authors:  M P Benoy; K A Elliott
Journal:  Biochem J       Date:  1937-08       Impact factor: 3.857

2.  Carbonated beverages and chronic kidney disease.

Authors:  Tina M Saldana; Olga Basso; Rebecca Darden; Dale P Sandler
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

Review 3.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

4.  Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice.

Authors:  Takuji Ishimoto; Miguel A Lanaspa; Myphuong T Le; Gabriela E Garcia; Christine P Diggle; Paul S Maclean; Matthew R Jackman; Aruna Asipu; Carlos A Roncal-Jimenez; Tomoki Kosugi; Christopher J Rivard; Shoichi Maruyama; Bernardo Rodriguez-Iturbe; Laura G Sánchez-Lozada; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 5.  Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.

Authors:  Takahiko Nakagawa; Katherine R Tuttle; Robert A Short; Richard J Johnson
Journal:  Nat Clin Pract Nephrol       Date:  2005-12

6.  Role of the kidney in the metabolism of fructose in 60-hour fasted humans.

Authors:  O Björkman; P Felig
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

7.  Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans.

Authors:  A D Baron; H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 8.  Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.

Authors:  Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2007-06

Review 9.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

10.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  14 in total

Review 1.  Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

Authors:  Algera Goga; Markus Stoffel
Journal:  Nat Rev Drug Discov       Date:  2022-02-24       Impact factor: 84.694

Review 2.  The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout.

Authors:  Xin-Yu Fang; Liang-Wei Qi; Hai-Feng Chen; Peng Gao; Qin Zhang; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Nutr       Date:  2022-06-22

3.  Ultrasound Assessment of the Relevance of Liver, Spleen, and Kidney Dimensions with Body Parameters in Adolescents.

Authors:  Ying Huang; Yumei Zheng; Cuncheng Zhang; Shigen Zhong
Journal:  Comput Math Methods Med       Date:  2022-07-04       Impact factor: 2.809

4.  High-Fructose Diet Increases Renal ChREBPβ Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome.

Authors:  Ariel Bier; Eliyahu Shapira; Rawan Khasbab; Yehonatan Sharabi; Ehud Grossman; Avshalom Leibowitz
Journal:  Biology (Basel)       Date:  2022-04-18

Review 5.  Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.

Authors:  Hitoshi Nishizawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2022-01-19       Impact factor: 3.872

Review 6.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

7.  Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.

Authors:  Louise Woodhams; Tin Fei Sim; Leanne Chalmers; Bu Yeap; Daniel Green; Markus Schlaich; Carl Schultz; Graham Hillis
Journal:  PeerJ       Date:  2021-04-19       Impact factor: 2.984

8.  Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.

Authors:  Kimio Watanabe; Masaaki Nakayama; Tae Yamamoto; Gen Yamada; Hiroshi Sato; Mariko Miyazaki; Sadayoshi Ito
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

Review 9.  Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.

Authors:  Takahiko Nakagawa; Laura G Sanchez-Lozada; Ana Andres-Hernando; Hideto Kojima; Masato Kasahara; Bernardo Rodriguez-Iturbe; Petter Bjornstad; Miguel A Lanaspa; Richard J Johnson
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 10.  Fructose contributes to the Warburg effect for cancer growth.

Authors:  Takahiko Nakagawa; Miguel A Lanaspa; Inigo San Millan; Mehdi Fini; Christopher J Rivard; Laura G Sanchez-Lozada; Ana Andres-Hernando; Dean R Tolan; Richard J Johnson
Journal:  Cancer Metab       Date:  2020-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.